These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 24617901)
1. IKVAV regulates ERK1/2 and Akt signalling pathways in BMMSC population growth and proliferation. Li B; Qiu T; Zhang P; Wang X; Yin Y; Li S Cell Prolif; 2014 Apr; 47(2):133-45. PubMed ID: 24617901 [TBL] [Abstract][Full Text] [Related]
2. Osteocalcin Induces Proliferation via Positive Activation of the PI3K/Akt, P38 MAPK Pathways and Promotes Differentiation Through Activation of the GPRC6A-ERK1/2 Pathway in C2C12 Myoblast Cells. Liu S; Gao F; Wen L; Ouyang M; Wang Y; Wang Q; Luo L; Jian Z Cell Physiol Biochem; 2017; 43(3):1100-1112. PubMed ID: 28977794 [TBL] [Abstract][Full Text] [Related]
3. Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells. Hu C; Huang L; Gest C; Xi X; Janin A; Soria C; Li H; Lu H J Hematol Oncol; 2012 Jul; 5():16. PubMed ID: 22534171 [TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways. Choi SC; Kim SJ; Choi JH; Park CY; Shim WJ; Lim DS Stem Cells Dev; 2008 Aug; 17(4):725-36. PubMed ID: 18788932 [TBL] [Abstract][Full Text] [Related]
5. PI3K/Akt and ERK1/2 signalling pathways are involved in endometrial cell migration induced by 17beta-estradiol and growth factors. Gentilini D; Busacca M; Di Francesco S; Vignali M; Viganò P; Di Blasio AM Mol Hum Reprod; 2007 May; 13(5):317-22. PubMed ID: 17350964 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma. Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438 [TBL] [Abstract][Full Text] [Related]
7. Activation of Akt and ERK signalling pathways induced by etoposide confer chemoresistance in gastric cancer cells. Liu SQ; Yu JP; Yu HG; Lv P; Chen HL Dig Liver Dis; 2006 May; 38(5):310-8. PubMed ID: 16527552 [TBL] [Abstract][Full Text] [Related]
8. NGF promotes cell cycle progression by regulating D-type cyclins via PI3K/Akt and MAPK/Erk activation in human corneal epithelial cells. Hong J; Qian T; Le Q; Sun X; Wu J; Chen J; Yu X; Xu J Mol Vis; 2012; 18():758-64. PubMed ID: 22509106 [TBL] [Abstract][Full Text] [Related]
9. Carboxymethylated chitosan stimulates proliferation of Schwann cells in vitro via the activation of the ERK and Akt signaling pathways. He B; Liu SQ; Chen Q; Li HH; Ding WJ; Deng M Eur J Pharmacol; 2011 Sep; 667(1-3):195-201. PubMed ID: 21699895 [TBL] [Abstract][Full Text] [Related]
10. Protein O-fucosyltransferase 1 promotes trophoblast cell proliferation through activation of MAPK and PI3K/Akt signaling pathways. Liu C; Liang X; Wang J; Zheng Q; Zhao Y; Khan MN; Liu S; Yan Q Biomed Pharmacother; 2017 Apr; 88():95-101. PubMed ID: 28103512 [TBL] [Abstract][Full Text] [Related]
11. Antimitogenic and proapoptotic activities of methylseleninic acid in vascular endothelial cells and associated effects on PI3K-AKT, ERK, JNK and p38 MAPK signaling. Wang Z; Jiang C; Ganther H; Lü J Cancer Res; 2001 Oct; 61(19):7171-8. PubMed ID: 11585751 [TBL] [Abstract][Full Text] [Related]
12. Bone marrow mesenchymal stem cells promote head and neck cancer progression through Periostin-mediated phosphoinositide 3-kinase/Akt/mammalian target of rapamycin. Liu C; Feng X; Wang B; Wang X; Wang C; Yu M; Cao G; Wang H Cancer Sci; 2018 Mar; 109(3):688-698. PubMed ID: 29284199 [TBL] [Abstract][Full Text] [Related]
13. γ-Enolase C-terminal peptide promotes cell survival and neurite outgrowth by activation of the PI3K/Akt and MAPK/ERK signalling pathways. Hafner A; Obermajer N; Kos J Biochem J; 2012 Apr; 443(2):439-50. PubMed ID: 22257123 [TBL] [Abstract][Full Text] [Related]
14. Crosstalk of EGF-directed MAPK signalling pathways and its potential role on EGF-induced cell proliferation and COX-2 expression in human mesenchymal stem cells. Sabri A; Ziaee AA; Ostad SN; Alimoghadam K; Ghahremani MH Cell Biochem Funct; 2011; 29(1):64-70. PubMed ID: 21264892 [TBL] [Abstract][Full Text] [Related]
15. [Salidroside via ERK1/2 and PI3K/AKT/mTOR signal pathway induces mouse bone marrow mesenchymal stem cells differentiation into neural cells]. Chen YN; Liu H; Zhao HB; Liu Y; Bai J; Zhu XJ; Wang Y Yao Xue Xue Bao; 2013 Aug; 48(8):1247-52. PubMed ID: 24187831 [TBL] [Abstract][Full Text] [Related]
16. High density lipoprotein cholesterol promotes the proliferation of bone-derived mesenchymal stem cells via binding scavenger receptor-B type I and activation of PI3K/Akt, MAPK/ERK1/2 pathways. Xu J; Qian J; Xie X; Lin L; Ma J; Huang Z; Fu M; Zou Y; Ge J Mol Cell Biochem; 2012 Dec; 371(1-2):55-64. PubMed ID: 22886428 [TBL] [Abstract][Full Text] [Related]
17. Andrographolide acts through inhibition of ERK1/2 and Akt phosphorylation to suppress chemotactic migration. Tsai HR; Yang LM; Tsai WJ; Chiou WF Eur J Pharmacol; 2004 Sep; 498(1-3):45-52. PubMed ID: 15363974 [TBL] [Abstract][Full Text] [Related]
18. Green tea (-)-epigallocatechin gallate inhibits the growth of human villous trophoblasts via the ERK, p38, AMP-activated protein kinase, and protein kinase B pathways. Shih LJ; Chen TF; Lin CK; Liu HS; Kao YH Am J Physiol Cell Physiol; 2016 Aug; 311(2):C308-21. PubMed ID: 27147558 [TBL] [Abstract][Full Text] [Related]
19. Small cytoplasmic domain peptides of natriuretic peptide receptor-C attenuate cell proliferation through Gialpha protein/MAP kinase/PI3-kinase/AKT pathways. Hashim S; Li Y; Anand-Srivastava MB Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H3144-53. PubMed ID: 16920814 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of fucosyltransferase IV promotes A431 cell proliferation through activating MAPK and PI3K/Akt signaling pathways. Yang XS; Liu S; Liu YJ; Liu JW; Liu TJ; Wang XQ; Yan Q J Cell Physiol; 2010 Nov; 225(2):612-9. PubMed ID: 20506505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]